Overview

Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)

Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The investigators will examine whether 2-cycles of DFP chemotherapy before definitive concurrent chemoradiation therapy (CCRT) can improve progression-free survival in locally advanced (Stage III & IVM0) hypopharyngeal and base of tongue carcinoma compared to definitive CCRT alone.
Phase:
Phase 2
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Cisplatin
Docetaxel
Fluorouracil